Browse > Article

A Study of Estrogen only Therapy and Estrogen Plus Androgen Combination Therapy in Surgical Menopause Patients  

Bai, Kwang-Bum (Department of Obstetrics and Gynecology, College of Medicine, Seoul National University)
Publication Information
Clinical and Experimental Reproductive Medicine / v.29, no.4, 2002 , pp. 279-285 More about this Journal
Abstract
Objective : To evaluate the difference between estrogen only therapy and estrogen-androgen combination therapy in surgical menopause patients. Materials and Method: Surgical menopause patients received 0.625 mg conjugated equine estrogens or 0.625 mg conjugated equine estrogens plus 1.25 mg methyltestosterone for 2 years. Bone mineral density, menopausal symptoms, lipoprotein profiles were measured. Results: Both groups showed increased bone mineral density. In the combination group, total cholestero l, high density lipoprotein cholesterol and triglycerides decreased. In the estrogen only group, low density lipoprotein cholesterol decreased but high density lipoprotein cholesterol increased significantly. In both groups, menopausal symptoms were much improved. Side effects were easily tolerated in both groups. Conclusions: Estrogen-androgen combination therapy had comparable benefits compared with estrogen only therapy.
Keywords
Estrogen-androgen therapy; Surgical menopause;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Adashi EY. The climacteric ovary as a functional gonadotropin-driven androgen-producting gland. Fetil Steril 1994; 62: 20-7   DOI
2 Kuritz SJ, Landis JR, Koch GG. A general overview of Mantel-Haenszel methods: Applications and recent developments. Annu Rev Public Health 1988;9: 123-60   DOI   ScienceOn
3 Miller VT, Muesing RA, LaRosa JC, Story DB, Philips EA, Stillman RJ. Effects of conjugated equine estrogen with and without three different progestogens on lipoproteins, high-density lipoprotein subfractions, and apolipoprotein A-I. Obstet Gynecol 1991; 77: 235-40   DOI   PUBMED   ScienceOn
4 Notelovitz M. Osteoporosis: Screening, prevention, and management. Fertil Steril 1993; 59: 707-27   DOI   PUBMED
5 Kupperman HS, Wetchler BB, Blatt MHG. Contemporary therapy of the menopausal syndrome. JAMA 1959; 171: 1627-37   DOI
6 Lufkin EG, Wahner HW, O'Fallon WM, et al. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intem Med 1994; 117: 1-9
7 Quigley MET, Martin PL, Bumier AM, Brooks P. Estrogen therapy arrests bone loss in elderly women. Am J Obstet Gynecol 1987; 156: 1516-23   DOI
8 Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991; 325: 1196-204   DOI   PUBMED   ScienceOn
9 Sarrel PM. Ovarian hormones and the circulation. Maturitas 1990;590: 287-98
10 Harris ST, Genant HK, Baylink DJ, et al. The effects of estrone (Ogen) on spinal bone density of postmenopausal women. Arch Intern Med 1991; 151:1980-4   DOI
11 Burger HG, Hailes J, Menelaus M, Nelson J, Hudson B, Balazs N. The management of persistent menopausal symptoms with oestradiol-testosterone implants: Clinical, lipid and hormonal results. Maturitas 1984; 6: 351-8   DOI
12 Davidson BJ, Ross RK, Paganini-Hill A, Hammond GD, Siiteri PK, Judd HL. Total and free estrogens and androgens in postmenopausal women with hip fractures. J Clin Endocrinol Metab 1982; 54: 115-20   DOI
13 Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502   PUBMED
14 Adami S, Suppi R, Bertoldo F, et al. Transdermal estradiol in the treatment of postmenopausal bone loss. Bone Miner 1987; 7: 79-86   DOI   ScienceOn
15 Chesnut CH III, Ivey JL, Gruber HE, et al. Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action. Metabolism 1983; 32: 571-80   DOI   ScienceOn
16 Erdtsieck RJ, Pols HAP, van Kuijk C, et al. Course of bone mass during and after hormone replacement therapy with and without addition of nandrolone decanoate. J Bone Miner Res 1994;9: 227-83
17 Hickock LR, Toomey C, Speroff L. A comparison of esterified estrogens with and without methyl-testosterone: Effects on endometrial histology and serum lipoproteins in postmenopausal women. Obstet Gynecol 1993; 82: 919-24
18 Johansson BW, Kaij L, Kullander S, Lenner H-C, Svanberg L, Astedt B. On some late effects of bilateral oophorectomy in the age range 15-30 years. Acta Obstet Gynecol Scand 1975; 54: 449-61   DOI   PUBMED   ScienceOn
19 Gonen R, Sharf M, Lavie P. The association between mid-sleep waking episodes and hot flushes in post-menopausal women. J Psychosom Obstet Gynecol 1986; 5:113-7   DOI
20 Greene JG, Cooke DJ. Life stress and symptoms at the climacterium. Br J Psychiatry 1980; 136: 486-91   DOI
21 Weiss NS, Ure CL, Ballard JH, Williams AR, Daling JR. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N EngI J Med 1980;303: 1995-8
22 Sherwin BB, Gelfand MM. Transactions of the 40th annual meeting of the society of Obstetricians and Gynaecologists of Canada: Differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause. Am J Obstet Gynecol 1985; 151: 153-60   DOI   PUBMED
23 Myers LS, Dixen J, Morrissette D, Carmichael M, Davidson JM. Effects of estrogen, androgen, and progestin on sexual psychophysiology and behavior in postmenopausal women. J Clin Endocrinol Metab 1990; 70: 1124-31   DOI